1. South Africa Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: generic
Numeral Limited

Numeral Limited

JJSE:XII
25.00
ZAC
-5.00
(-16.67%)
42.25BMarket Cap
2012 Y
2013 Y
2014 Y
2015 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.04
-0.44
-0.37
0.01
0.01
- -
-0.39
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.99
0.52
0.13
0.14
0.38
0.39
-0.01
- -
- -
-0.01
- -
0.01
- -
- -
Tangible Book Value per Share
0.99
0.52
0.13
0.14
0.05
0.39
-0.01
- -
- -
-0.01
- -
- -
- -
- -
Basic Weighted Avg Shares
10
10
10
10
90
90
90
90
90
77
124
1,243
1,243
124
Sales/Revenue/Turnover
- -
- -
- -
- -
2
- -
- -
- -
- -
- -
- -
1
2
- -
Operating Margin (%)
- -
- -
- -
- -
54.67
- -
- -
- -
- -
- -
25.82
79.27
77.28
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-4
-4
- -
1
- -
-35
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
15.55
- -
- -
- -
- -
- -
- -
- -
94.19
- -
Profit Margin (%)
- -
- -
- -
- -
31.63
- -
- -
- -
- -
- -
26.04
15.59
3.63
- -
Working Capital
- -
- -
- -
- -
1
- -
-1
- -
- -
- -
- -
1
1
1
LT Debt
- -
- -
- -
- -
3
- -
- -
- -
- -
- -
- -
4
4
4
Total Equity
10
5
1
1
34
35
-1
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
2.18
- -
- -
- -
- -
- -
- -
- -
2.35
- -
Return on Capital (%)
- -
- -
- -
- -
4.28
- -
- -
- -
- -
- -
-34.68
- -
4.54
- -
Return on Common Equity (%)
-3.91
-58.07
-113.21
9.23
3.21
-0.2
- -
- -
- -
- -
- -
- -
11.48
- -

Capital Structure

USD

•

in mil. unless spec.
Nov'26
Feb'26
May'27
ST Debt
- -
- -
- -
LT Borrowings
5
4
4
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,243
1,243
1,243
Market Capitalization
15
31
26

Working Capital

USD

•

in mil. unless spec.
Nov'26
Feb'26
May'27
Total Current Assets
2
2
2
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
1
1
1
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
195.35%
-57.65%
-14.23%
Free Cash Flow
- -
- -
-73.69%
Net Income, GAAP
5,021.68%
80.27%
-47.41%
Sales/Revenue/Turnover
- -
- -
125.68%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
1
1
2026
- -
- -
1
- -
2
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
0.01
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Patrick David Wysoczanski
Full Time Employees
5
Sector
Health technology
Industry
Pharmaceuticals: generic
Address
Sayed Hossen Road Pretoria GT South Africa 73550
IPO Date
Dec 27, 2023
Website
numeral.co.za
Similar Companies
Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Teva Pharmaceutical Industries Limited (TASE:TEVA)
Jagsonpal Pharmaceuticals Ltd. (NSE:JAGSNPHARM)
Zim Laboratories Ltd. (NSE:ZIMLAB)
Paradigm Biopharmaceuticals Ltd. (ASX:PAR)
Neuren Pharmaceuticals Limited (ASX:NEU)
Business
Numeral Limited operates as a diversified financial services company focused on fintech-enabled asset management and related financial services. Headquartered in Mauritius with a footprint across Africa, Europe and Asia, the firm was founded in 2010 and maintains its principal offices in Paris, Île-de-France, France, for European operations. Core business activity centers on investment management, financial technology-enabled back-office solutions, and advisory services. Main Products and Services: Investment management and wealth services; fintech-enabled subledger and data reconciliation platforms; automated accounting and revenue recognition tooling; cash and transaction reconciliation; tax compliance and regulatory reporting support; corporate finance advisory and transaction processing; technology-enabled outsourcing for financial operations; legal, HR, and specialized administrative support services; strategic advisory for growth-stage and high-volume businesses; cross-border financial services and custody support. Latest Major Company Changes: Numeral Limited completes strategic expansion in 2024–2025 by acquiring a South African subsidiary Numeral Financial Services Proprietary Limited to deepen regional capabilities; enters partnerships to expand fintech data integration and processing capabilities; launches enhanced subledger and data reconciliation products in 2023–2025 to support higher transaction volumes; evolves branding and corporate structure to reflect broader fintech focus; undertakes targeted regional hires to support expanded operations across Africa and Europe. Industry and business segments: Financial services; fintech; asset management; corporate services; technology-enabled back-office and reconciliation solutions. Target markets include high-volume ecommerce, software-as-a-service platforms, asset managers, and mid-to-large corporates requiring scalable financial operations, revenue recognition, and reporting automation. Geographic operations span Mauritius, South Africa, Europe (notably France/France-based entities), and other international markets through partnerships and subsidiary networks. Subsidiaries and parent relationships include Numeral Financial Services Proprietary Limited (SA) as a key regional unit, with parent governance and cross-border collaboration across Numeral affiliates. Founded year and headquarters: 2010; headquarters in Mauritius with key European presence in Paris.